Klebsiella pneumoniae bacteriophage, 20 ml, 4 pcs.

The Klebsiella pneumoniae bacteriophage (Klebsifag) is an immunobiological preparation.

It has the ability to specifically lyse Klebsiella pneumoniae bacteria.

It is intended for treatment of purulent-septic and enteric diseases caused by Klebsiella pneumoniae bacteria: surgical infections, urogenital diseases, gastrointestinal tract, purulent inflammatory diseases of ear, throat, nose, respiratory and lungs, generalized septic diseases, purulent-septic diseases of newborns.

Indications

Bacteriophage Klebsiella pneumoniae (Klebsifag) is intended for the treatment of purulent-septic and enteral diseases caused by the bacteria Klebsiella pneumoniae:

surgical infections (suppuration, wounds, peritonitis, pleurisy, burns, mastitis, abscess, phlegmon, osteomyelitis, etc.);
diseases of the urogenital area (cystitis, pyelonephritis, urethritis, colpitis, endometritis, sallingoophoritis, etc.);
diseases of the gastrointestinal tract (gastroeterocolitis, cholecystitis, intestinal dysbiosis);
purulent-inflammatory diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy);
generalized septic diseases;
purulent-septic diseases of newborns: neonatal sepsis, omphalitis, pyoderma, pemphigus, gastroenterocolitis.
The bacteriophage of Klebsiella pneumoniae (Klebsifag) is also used for selective decontamination of the intestine when contaminated with nosocomial strains of Klebsiella pneumoniae.

Pharmacological effect

Bacteriophage Klebsiella pneumonia (Klebsifag) is an immunobiological preparation.

It has the ability to specifically lyse Klebsiella pneumoniae bacteria.

Intended for the treatment of purulent-septic and enteral diseases caused by the bacteria Klebsiella pneumonia: surgical infections, diseases of the urogenital area, gastrointestinal tract, purulent-inflammatory diseases of the ear, throat, nose, respiratory tract and lungs, generalized septic diseases, purulent-septic diseases of newborns.

Special instructions

The opening of bottles and ampoules and the procedure for administering the drug are carried out in strict compliance with antiseptic rules.

If the integrity of the packaging and labeling is damaged or the drug becomes cloudy, do not use it.

Storage of Klebsiella pneumoniae bacteriophage (Klebsiphage) after opening the bottle or ampoule is not allowed.

Active ingredient

Bacteriophage Klebsiella pneumonia

Composition

The drug is a filtrate of phagolysates, active against Klebsiella pneumoniae.

Contraindications

Hypersensitivity to the components of the drug.

Side Effects

Allergic reactions.

Storage conditions

In a dry place, protected from light, at a temperature of 2–8°C.

Shelf life

2 years.

Manufacturer

Microgen NPO, Russia